Bio-Rad Laboratories BIO Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories's operating cash flow?
- Bio-Rad Laboratories (BIO) reported operating cash flow of $108.1M in Q1 2026.
- How has Bio-Rad Laboratories's operating cash flow changed year-over-year?
- Bio-Rad Laboratories's operating cash flow decreased by 16.8% year-over-year, from $129.9M to $108.1M.
- What is the long-term trend for Bio-Rad Laboratories's operating cash flow?
- Over 4 years (2021 to 2025), Bio-Rad Laboratories's operating cash flow has grown at a -5.6% compound annual growth rate (CAGR), from $669.46M to $532.2M.
- What does operating cash flow mean?
- The net cash flow generated by the company's core business operations.
- How do you interpret operating cash flow?
- A consistent increase indicates a healthy, self-sustaining business model, while a decrease may signal operational inefficiencies or working capital strain.
- How does operating cash flow compare across companies?
- A critical benchmark for all public companies; peers with higher margins typically demonstrate stronger operating cash flow conversion.